{
    "Trade/Device Name(s)": [
        "SPOTFIRE RSP Pos & Neg Controls (M425)",
        "SPOTFIRE RSP Positive Control (M42638)",
        "SPOTFIRE RSP Negative Control (M42738)"
    ],
    "Submitter Information": "Maine Molecular Quality Controls, Inc.",
    "510(k) Number": "K233611",
    "Predicate Device Reference 510(k) Number(s)": [
        "K230868"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "November 3, 2023",
    "Summary Letter Received Date": "November 13, 2023",
    "Submission Date": "March 19, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed Quality Control Material For Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Bordetella parapertussis",
        "Bordetella pertussis",
        "Chlamydia pneumoniae",
        "Mycoplasma pneumoniae",
        "Streptococcus dysgalactiae (Group C/G Strep)",
        "Streptococcus pyogenes (Group A Strep)",
        "Adenovirus",
        "Coronavirus SARS-CoV-2",
        "Coronavirus (seasonal)",
        "Human Metapneumovirus",
        "Human Rhinovirus/Enterovirus",
        "Influenza A Subtype H1-2009",
        "Influenza A Subtype H3",
        "Influenza B",
        "Parainfluenza Virus",
        "Respiratory Syncytial Virus"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Throat swab"
    ],
    "Specimen Container(s)": [
        "Transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "BIOFIRE SPOTFIRE System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing",
        "Reverse transcription",
        "Amplification",
        "Detection",
        "Identification"
    ],
    "Methodologies": [
        "In vitro RNA transcript control",
        "Molecular quality control"
    ],
    "Submission Type(s)": [
        "Quality control material",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for SPOTFIRE RSP Pos & Neg Controls as external assayed quality control for molecular respiratory pathogen panels on BIOFIRE SPOTFIRE System",
    "Indications for Use Summary": "External positive and negative controls to monitor in vitro nucleic acid testing for detection of listed respiratory and sore throat pathogens using BIOFIRE SPOTFIRE Respiratory (R) Panel, Respiratory (R) Panel Mini, and Respiratory/Sore Throat (R/ST) Panel on the BIOFIRE SPOTFIRE System.",
    "fda_folder": "Microbiology"
}